Bionano genomics announces closing of $230 million underwritten public offering of common stock and full exercise of underwriters' option to purchase additional shares

San diego, jan. 25, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), announced today the closing of its previously announced underwritten public offering of 38,333,352 shares of its common stock, including 5,000,002 shares sold pursuant to the underwriters' exercise in full of their option to purchase additional shares, at a price to the public of $6.00 per share. the gross proceeds to bionano from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $230 million.
BNGO Ratings Summary
BNGO Quant Ranking